Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |